The most common non‐hematologic AEs, regardless of causality, were arthralgia and/or myalgia (n = 40, in 24 patients), symptoms related to PEG‐IFNα2 injection (flu‐like symptoms, injection site reactions; n = 36, in 24 patients), and gastrointestinal symptoms (nausea, abdominal pain, dyspepsia, diarrhea; n = 31, in 27 patients; Appendix S7). The gene discussed is IFNA2; the disease is Myalgia.